Bank Pictet & Cie (Asia)’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | $335K | Hold |
1,444
| – | – | 0.02% | 75 |
|
2024
Q1 | $311K | Sell |
1,444
-3,639
| -72% | -$785K | 0.02% | 79 |
|
2023
Q4 | $1.32M | Hold |
5,083
| – | – | 0.33% | 66 |
|
2023
Q3 | $1.31M | Buy |
5,083
+1,259
| +33% | +$324K | 0.39% | 53 |
|
2023
Q2 | $1.09M | Hold |
3,824
| – | – | 0.32% | 71 |
|
2023
Q1 | $1.06M | Sell |
3,824
-41
| -1% | -$11.4K | 0.36% | 69 |
|
2022
Q4 | $1.07M | Buy |
3,865
+658
| +21% | +$182K | 0.38% | 62 |
|
2022
Q3 | $856K | Sell |
3,207
-2,640
| -45% | -$705K | 0.34% | 58 |
|
2022
Q2 | $1.19M | Sell |
5,847
-1,164
| -17% | -$237K | 0.4% | 41 |
|
2022
Q1 | $1.48M | Buy |
7,011
+1,597
| +29% | +$336K | 0.4% | 49 |
|
2021
Q4 | $1.3M | Buy |
5,414
+1,546
| +40% | +$371K | 0.31% | 68 |
|
2021
Q3 | $1.1M | Buy |
3,868
+276
| +8% | +$78.1K | 0.3% | 70 |
|
2021
Q2 | $1.24M | Sell |
3,592
-1,124
| -24% | -$389K | 0.35% | 64 |
|
2021
Q1 | $1.32M | Buy |
4,716
+1,577
| +50% | +$441K | 0.41% | 49 |
|
2020
Q4 | $769K | Hold |
3,139
| – | – | 0.24% | 74 |
|
2020
Q3 | $890K | Sell |
3,139
-69
| -2% | -$19.6K | 0.34% | 61 |
|
2020
Q2 | $858K | Hold |
3,208
| – | – | 0.37% | 54 |
|
2020
Q1 | $1.02M | Sell |
3,208
-628
| -16% | -$199K | 0.49% | 31 |
|
2019
Q4 | $1.14M | Sell |
3,836
-16
| -0.4% | -$4.75K | 0.49% | 32 |
|
2019
Q3 | $897K | Hold |
3,852
| – | – | 0.4% | 44 |
|
2019
Q2 | $901K | Hold |
3,852
| – | – | 0.41% | 43 |
|
2019
Q1 | $911K | Buy |
3,852
+1,450
| +60% | +$343K | 0.43% | 38 |
|
2018
Q4 | $723K | Hold |
2,402
| – | – | 0.39% | 51 |
|
2018
Q3 | $849K | Sell |
2,402
-626
| -21% | -$221K | 0.39% | 49 |
|
2018
Q2 | $879K | Buy |
+3,028
| New | +$879K | 0.4% | 68 |
|
2015
Q3 | – | Sell |
-760
| Closed | -$307K | – | 40 |
|
2015
Q2 | $307K | Hold |
760
| – | – | 1.04% | 21 |
|
2015
Q1 | $321K | Buy |
+760
| New | +$321K | 0.24% | 54 |
|